Skip to content
February 20, 2024

Equity.Guru

Investment information for the new generation

Search

CYBN.NE

In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is…
In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is…
Cybin (CYBN.NEO), a Canadian-based biopharmaceutical company working to transform psychedelics into therapeutics, announced today that it had received approval from an independent ethics committee in the Netherlands to commence…
We’re living in interesting times and I mean that in the Chinese curse kind of way. We can’t seem to stop to catch our breath when it comes to…
Detroit, Michigan city officials announced on Monday that they had decriminalized psychedelics, becoming the latest municipality to pull back on law enforcement when it comes to plant-based mind-manifesting substances….
Interest in the psychedelic market is as high as Matt Gaetz and Joel Greenberg on a night out, but the accompanying FOMO has the potential to muddy the market,…
The psychedelics space is one of the hottest investment trips in the public markets today. Embryonic, wide open to possibility and with mounting scientific evidence of psychedelics’ healing properties,…
Revive Therapeutics (RVV.C) joined the AdvisorShares Psychedelics ETF (PSIL.NYSE) today, in time for its launch, according to a press release.   If you’re not entirely sure what an ETF…
Cruel, cruel summer It’s near the end of September and the seasons are changing.   Chet Hanks predicted this past summer would be a ‘white boy summer’. But for…
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been…